Gerresheimer (ETR:GXI)‘s stock had its “neutral” rating reaffirmed by stock analysts at DZ Bank in a research note issued to investors on Tuesday, Borsen Zeitung reports.
A number of other equities research analysts have also weighed in on the company. Deutsche Bank set a €83.00 ($96.51) target price on Gerresheimer and gave the company a “buy” rating in a research note on Tuesday. Hauck & Aufhaeuser set a €50.00 ($58.14) target price on Gerresheimer and gave the company a “sell” rating in a research note on Monday, March 25th. Goldman Sachs Group set a €65.00 ($75.58) target price on Gerresheimer and gave the company a “neutral” rating in a research note on Friday, March 22nd. HSBC set a €69.00 ($80.23) target price on Gerresheimer and gave the company a “neutral” rating in a research note on Wednesday, March 20th. Finally, JPMorgan Chase & Co. set a €54.70 ($63.60) target price on Gerresheimer and gave the company a “sell” rating in a research note on Tuesday, February 19th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. Gerresheimer has a consensus rating of “Hold” and an average price target of €68.34 ($79.46).
ETR GXI opened at €69.10 ($80.35) on Tuesday. Gerresheimer has a 1-year low of €51.10 ($59.42) and a 1-year high of €80.25 ($93.31). The company has a debt-to-equity ratio of 108.42, a current ratio of 0.74 and a quick ratio of 0.51. The stock has a market capitalization of $2.17 billion and a PE ratio of 16.82.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.